Objectives: To compare the efficacy and tolerability of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day used to attain a target serum urate concentration (sUr) ⩽0.30 mmol/l (5 mg/dl).

Over the past decades, the concept of ‘remission’ has emerged as a moniker for the disease state one would ideally like to achieve when a ‘cure’—the ultimate goal of medical intervention—cannot ...

1 The George Institute for Global Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia 4 Institute of Bone and Joint Research, The Kolling Institute, Sydney Medical ...

Background: The Bath Ankylosing Spondylitis Metrology Index (BASMI) characterises the spinal mobility of patients with ankylosing spondylitis. Two versions have been published using categorical scores ...

Objective Remission in rheumatoid arthritis (RA) is an increasingly attainable goal, but there is no widely used definition of remission that is stringent but achievable and could be applied uniformly ...

Objectives To compare over 2 years the safety, efficacy and radiographic outcomes of subcutaneous abatacept versus adalimumab, in combination with methotrexate (MTX), in patients with rheumatoid ...

4 National Institute of Environmental Health, Chinese Center for Disease Control and Prevention, Beijing, China Objectives To evaluate the associations of regular glucosamine use with all-cause and ...

1 School of Pharmacy and Pharmaceutical Sciences, The University of Manchester, Manchester, UK 2 Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, UK Correspondence to ...